glycosaminoglycans
Showing 26 - 50 of 131
Pulp Disease, Dental Trial (mineral trioxide aggregate pulpotomy, Dehydrated amniotic membrane pulpotomy, Hyaluronic acid
Not yet recruiting
- Pulp Disease, Dental
- mineral trioxide aggregate pulpotomy
- +2 more
- (no location specified)
Jul 31, 2023
Superficial Venous Thrombosis of Leg, Secondary Prevention Trial in Padova (Mesoglycan Oral Tablet, Placebo Oral Tablet)
Recruiting
- Superficial Venous Thrombosis of Leg, Secondary Prevention
- Mesoglycan Oral Tablet
- Placebo Oral Tablet
-
Padova, ItalyGiuseppe Camporese
Sep 8, 2021
Endothelial Dysfunction Trial in Valencia
Recruiting
- Endothelial Dysfunction
-
Valencia, SpainNuria Garcia Del Olmo
Jul 27, 2022
MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))
Recruiting
- MPS I
- +8 more
- Aldurazyme (laronidase)
-
San Francisco, CaliforniaUniversity of California
Apr 21, 2022
Chronic Ulcer of Leg or Foot, Diabetic Foot Ulcer, Arterial Ulcer Trial in Montpellier (CACIPLIQ20®)
Recruiting
- Chronic Ulcer of Leg or Foot
- +3 more
- CACIPLIQ20®
-
Montpellier, FranceRéseau Cicat-Occitanie
Feb 24, 2022
Urine Biomarker for Stone Recurrence
Recruiting
- Urolithiasis
-
Shatin, Hong KongPrince of Wales Hospital
Aug 3, 2021
Recurrent Urinary Tract Infection Trial in Basingstoke (Rigid cystoscopy with urethral dilatation, Flexible cystoscopy and
Withdrawn
- Recurrent Urinary Tract Infection
- Rigid cystoscopy with urethral dilatation
- Flexible cystoscopy and installation of Glycosaminoglycan layer replacement (laluril)
-
Basingstoke, Hampshire, United KingdomHampshire Hospitals NHS Foundation Trust
Sep 21, 2021
Mucopolysaccharidosis Type II, Metabolic Diseases Trial in Russian Federation (GNR-055 1.0-2.0-3.0 mg/kg, GNR-055 2.0 mg/kg,
Recruiting
- Mucopolysaccharidosis Type II
- Metabolic Diseases
- GNR-055 1.0-2.0-3.0 mg/kg
- +2 more
-
Ekaterinburg, Russian Federation
- +4 more
Jan 13, 2022
Mucopolysaccharidosis Type 3 B Trial in Worldwide (rAAV9.CMV.hNAGLU)
Terminated
- Mucopolysaccharidosis Type 3 B
- rAAV9.CMV.hNAGLU
-
Columbus, Ohio
- +3 more
Apr 29, 2022
Plasma Glycosaminoglycans as Diagnostic and Prognostic
Completed
- Renal Cell Carcinoma
- Glycosaminoglycan plasma score
- (no location specified)
Apr 16, 2018
Mucopolysaccharidosis I Trial in Wuhan (Laronidase)
Recruiting
- Mucopolysaccharidosis I
-
Wuhan, ChinaInvestigational Site Number :1560001
Jan 15, 2023
Atrophic Acne Scar Trial in Ho Chi Minh City (procedure, device, drug)
Active, not recruiting
- Atrophic Acne Scar
- Simultaneous combination of fractional CO2 laser and subcision
- +6 more
-
Ho Chi Minh City, VietnamHo Chi Minh City Hospital of Dermato - Venereology
Jan 14, 2023
Severe Acute Malnutrition Trial in Lusaka, Harare (Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC),
Completed
- Severe Acute Malnutrition
- Colostrum high protein powder (Neovite)
- +3 more
-
Lusaka, Zambia
- +2 more
Sep 21, 2021
Biomarkers for Hunter Syndrome
Active, not recruiting
- Hunter Syndrome
- +3 more
-
Cancun, Quintana Roo, Mexico
- +3 more
May 12, 2021
Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)
Active, not recruiting
- Lysosomal Storage Disease
- +4 more
-
Cairo, Egypt
- +4 more
May 17, 2021
Immediate Dental Implant Trial in Cairo (immediate dental implant, Hyaluronic Acid)
Completed
- Immediate Dental Implant
- immediate dental implant
- Hyaluronic Acid
-
Cairo, EgyptCairo University
Jun 5, 2021
Biomarker for Sly Disease (MPS VII) (BioSly)
Active, not recruiting
- Developmental Delay
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Skin Aging Trial in Bengaluru (Terminalia Chebula Fruit Extract, Placebo)
Completed
- Skin Aging
- Terminalia Chebula Fruit Extract
- Placebo
-
Bengaluru, Karnatka, IndiaMSCR
Jun 24, 2021
Human Cellular Disease Models for Morquio Disease
Completed
- Morquio Disease
-
Lahore, PakistanChildrens Hospital and Institute of Child Health, Ferozepur Road
Apr 8, 2021
Biomarker for Morquio Disease (BioMorquio)
Active, not recruiting
- Morquio Syndrome
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Renal Cancer Detection With Liquid Biopsy
Recruiting
- Renal Cancer
- Oncocytoma
- GaGnostic
-
Roskilde, DenmarkZealand University Hospital
Dec 10, 2021
Biomarker for Hurler Disease (BioHurler)
Active, not recruiting
- Mucopolysaccharidosis Type I
- +2 more
-
Cairo, Egypt
- +4 more
May 12, 2021